Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
WTM
|
Morgan W Davis
Director |
SELL
Open market or private sale
|
Indirect | 585 Reduced 11.27% |
$536,416
$916.95 p/Share
|
Apr 12
2019 |
GHDX
|
Baker Bros. Advisors LP
Director |
SELL
Open market or private sale
|
Indirect | 287,465 Reduced 1.13% |
$18,938,193
$65.88 p/Share
|
Apr 12
2019 |
DIS
|
Zenia B. Mucha
SEVP & Chief Comms Officer |
SELL
Open market or private sale
|
Direct | 33,000 Reduced 46.6% |
$4,259,310
$129.07 p/Share
|
Apr 12
2019 |
GHDX
|
Baker Bros. Advisors LP
Director |
SELL
Open market or private sale
|
Indirect | 11,204 Reduced 0.09% |
$731,845
$65.32 p/Share
|
Apr 12
2019 |
RNGR
|
B. Riley Financial, Inc. |
SELL
Open market or private sale
|
Indirect | 924 Reduced 0.48% |
$7,688
$8.32 p/Share
|
Apr 12
2019 |
AMR
|
Kevin S Crutchfield
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 5,001 Reduced 2.72% |
$288,158
$57.62 p/Share
|
Apr 12
2019 |
AADI
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 30,908 Reduced 0.64% |
$32,144
$1.04 p/Share
|
Apr 12
2019 |
CARG
|
Parafestas Anastasios
Director |
SELL
Open market or private sale
|
Indirect | 30,000 Reduced 0.21% |
$1,220,100
$40.67 p/Share
|
Apr 12
2019 |
MKL
|
Steven A Markel
Director |
SELL
Open market or private sale
|
Direct | 100 Reduced 0.1% |
$100,000
$1000.0 p/Share
|
Apr 12
2019 |
TRU
|
Timothy Elberfeld
SVP and CAO |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 7.11% |
$70,000
$70.0 p/Share
|
Apr 12
2019 |
SNX
|
Kevin M Murai
Director |
SELL
Open market or private sale
|
Direct | 542 Reduced 3.64% |
$57,961
$106.94 p/Share
|
Apr 12
2019 |
SNX
|
Kevin M Murai
Director |
SELL
Open market or private sale
|
Direct | 4,458 Reduced 23.02% |
$476,605
$106.91 p/Share
|
Apr 12
2019 |
LLY
|
Alfonso G Zulueta
SVP & President, Lilly Int'l |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 14.75% |
$1,246,500
$124.65 p/Share
|
Apr 12
2019 |
LLY
|
Melissa S Barnes
Chief Eth/Cmpl Ofcr & SVP, ERM |
SELL
Open market or private sale
|
Direct | 4,735 Reduced 17.65% |
$592,585
$125.15 p/Share
|
Apr 12
2019 |
MKL
|
Alan I Kirshner
Executive Chairman |
SELL
Open market or private sale
|
Direct | 200 Reduced 0.9% |
$200,500
$1002.5 p/Share
|
Apr 12
2019 |
ITRI
|
Scopia Capital Management LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 26,110 Reduced 0.59% |
$1,262,418
$48.35 p/Share
|
Apr 12
2019 |
CWK
|
Ontario Teachers Pension Plan Board
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 233,682 Reduced 1.47% |
$3,991,289
$17.08 p/Share
|
Apr 12
2019 |
SNPS
|
John Schwarz
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 52.74% |
$1,176,100
$117.61 p/Share
|
Apr 11
2019 |
DAL
|
W Gilbert West
Sr. EVP & COO |
SELL
Open market or private sale
|
Direct | 7,465 Reduced 7.41% |
$436,926
$58.53 p/Share
|
Apr 11
2019 |
DAL
|
Joanne D Smith
EVP & Chief People Officer |
SELL
Open market or private sale
|
Direct | 34,000 Reduced 26.65% |
$1,972,000
$58.0 p/Share
|
Apr 11
2019 |
GHDX
|
Baker Bros. Advisors LP
Director |
SELL
Open market or private sale
|
Indirect | 202,281 Reduced 0.78% |
$13,554,850
$67.01 p/Share
|
Apr 11
2019 |
RNGR
|
B. Riley Financial, Inc. |
SELL
Open market or private sale
|
Indirect | 779 Reduced 0.4% |
$6,536
$8.39 p/Share
|
Apr 11
2019 |
PEN
|
Adam Elsesser
CEO and President |
SELL
Open market or private sale
|
Indirect | 8,000 Reduced 0.18% |
$1,143,120
$142.89 p/Share
|
Apr 11
2019 |
AMR
|
Kevin S Crutchfield
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 4,999 Reduced 2.72% |
$292,442
$58.5 p/Share
|
Apr 11
2019 |
CVX
|
James William Johnson
Executive Vice President |
SELL
Open market or private sale
|
Direct | 4,750 Reduced 100.0% |
$597,693
$125.83 p/Share
|
Apr 11
2019 |
AADI
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 57,438 Reduced 1.17% |
$62,033
$1.08 p/Share
|
Apr 11
2019 |
CARG
|
Parafestas Anastasios
Director |
SELL
Open market or private sale
|
Indirect | 30,000 Reduced 0.41% |
$1,199,400
$39.98 p/Share
|
Apr 11
2019 |
SSNT
|
Stanley Wunderlich
Director |
SELL
Open market or private sale
|
Direct | 1,250 Reduced 7.25% |
$3,625
$2.9 p/Share
|
Apr 11
2019 |
PGTK
|
Fresh Air Investments (Canada) Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 110,000 Reduced 1.76% |
$198,000
$1.8 p/Share
|
Apr 10
2019 |
AADI
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 140,230 Reduced 2.77% |
$152,851
$1.09 p/Share
|
Apr 10
2019 |
GHDX
|
Baker Bros. Advisors LP
Director |
SELL
Open market or private sale
|
Indirect | 124,542 Reduced 0.95% |
$8,556,035
$68.7 p/Share
|
Apr 10
2019 |
GHDX
|
Baker Bros. Advisors LP
Director |
SELL
Open market or private sale
|
Indirect | 13,146 Reduced 0.1% |
$908,652
$69.12 p/Share
|
Apr 10
2019 |
TSLA
|
Antonio J. Gracias
Director |
SELL
Open market or private sale
|
Direct | 15,480 Reduced 74.74% |
$4,273,409
$276.06 p/Share
|
Apr 10
2019 |
CARG
|
Parafestas Anastasios
Director |
SELL
Open market or private sale
|
Indirect | 30,000 Reduced 0.41% |
$1,180,800
$39.36 p/Share
|
Apr 10
2019 |
FSLR
|
Mark R Widmar
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 33,371 Reduced 17.95% |
$2,002,260
$60.0 p/Share
|
Apr 10
2019 |
K
|
Kellogg W K Foundation Trust |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 0.15% |
$5,717,000
$57.17 p/Share
|
Apr 10
2019 |
SQ
|
Jack Dorsey
Block Head and Chairperson |
SELL
Open market or private sale
|
Indirect | 68,690 Reduced 95.19% |
$5,131,830
$74.71 p/Share
|
Apr 10
2019 |
SNPS
|
Steven Walske
Director |
SELL
Open market or private sale
|
Direct | 2,109 Reduced 11.34% |
$246,500
$116.88 p/Share
|
Apr 10
2019 |
AMR
|
John E Lushefski
Director |
SELL
Open market or private sale
|
Direct | 2,750 Reduced 15.76% |
$161,590
$58.76 p/Share
|
Apr 10
2019 |
AMR
|
Harvey L Tepner
Director |
SELL
Open market or private sale
|
Direct | 750 Reduced 2.9% |
$43,905
$58.54 p/Share
|
Apr 10
2019 |
ADBE
|
John E Warnock
Director |
SELL
Open market or private sale
|
Indirect | 1,177 Reduced 0.26% |
$317,166
$269.47 p/Share
|
Apr 10
2019 |
WTM
|
Morgan W Davis
Director |
SELL
Open market or private sale
|
Indirect | 412 Reduced 7.36% |
$376,976
$914.99 p/Share
|
Apr 10
2019 |
AADI
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 32,991 Reduced 0.65% |
$33,321
$1.01 p/Share
|
Apr 09
2019 |
GHDX
|
Baker Bros. Advisors LP
Director |
SELL
Open market or private sale
|
Indirect | 21,063 Reduced 0.08% |
$1,427,650
$67.78 p/Share
|
Apr 09
2019 |
KNSL
|
Frederick L. Russell Jr.
Director |
SELL
Open market or private sale
|
Indirect | 1,000 Reduced 2.06% |
$67,930
$67.93 p/Share
|
Apr 09
2019 |
PKDC
|
Whitebox Advisors LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 116,000 Reduced 7.57% |
$2,115,840
$18.24 p/Share
|
Apr 09
2019 |
TSLA
|
Antonio J. Gracias
Director |
SELL
Open market or private sale
|
Direct | 1,300 Reduced 14.89% |
$356,486
$274.22 p/Share
|
Apr 09
2019 |
CARG
|
Parafestas Anastasios
Director |
SELL
Open market or private sale
|
Indirect | 30,000 Reduced 0.41% |
$1,172,100
$39.07 p/Share
|
Apr 09
2019 |
ITRI
|
Scopia Capital Management LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 82 Reduced 0.0% |
$3,937
$48.01 p/Share
|
Apr 09
2019 |
DMS
|
Polar Asset Management Partners Inc.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 72,000 Reduced 3.48% |
$742,320
$10.31 p/Share
|
Apr 09
2019 |